Treatment of Fibromyalgia with Neurostimulation: a Randomized, Double-Blinded, Sham-Controlled Trial

Authors

Jeffrey Hargrove, Kettering UniversityFollow
R. Michael Gendreau, Gendreau Consulting, LLC, Cerephex Corporation
Donald Deering, St. Joseph Mercy- Oakland
Judith Gendreau, Gendreau Consulting, LLC

Document Type

Article

Publication Date

10-2014

Publication Title

Arthritis & Rheumatology

Abstract

Background/Purpose: NeuroPoint is a medical device designed to provide noninvasive brain stimulation using a proprietary approach to deliver very low energy levels to deep brain structures. NeuroPoint provides a therapy referred to as “reduced impedance noninvasive cortical electrostimulation” (RINCE). An initial feasibility study of 77 patients diagnosed with fibromyalgia (FM) was conducted between 2006 and 2008. The current pilot study was designed to further evaluate the safety and efficacy of RINCE therapy in the treatment of FM.

Volume

66

Issue

S10

First Page

483

ISSN

2326-5191

Rights

Copyright © 2014, John Wiley and Sons

Recommended Citation

Hargrove, Jeffrey; Gendreau, R. Michael; Deering, Donald; and Gendreau, Judith, "Treatment of Fibromyalgia with Neurostimulation: a Randomized, Double-Blinded, Sham-Controlled Trial" (2014). Mechanical Engineering Publications. 44.
https://digitalcommons.kettering.edu/mech_eng_facultypubs/44